Cannabis

In the realm of agronomy and crop management, the study of pollen dynamics remains a relatively underexplored field with significant implications for agricultural practices and regulatory frameworks. A novel investigation published in the journal *Scientific Reports* sheds light on the complexities of cannabis pollen dispersal, particularly focusing on its seasonal and conditional variances that contribute to the risk of cross-pollination …

Read more

The burgeoning field of cannabinoid research has once again captivated the attention of the scientific community, particularly with respect to cannabidiol (CBD). Recent literature has emerged that posits CBD as a promising candidate for the treatment of depression, supported by a review accepted for publication in the *International Journal of Neuropsychopharmacology*. This comprehensive review consolidates findings from various studies, revealing …

Read more

In the ongoing discourse surrounding the opioid crisis in the United States, a newly published analysis presents compelling evidence that legalizing recreational marijuana may play a significant role in mitigating opioid overdose deaths. The paper, recently posted on the Social Science Research Network (SSRN), reveals a “consistent negative relationship” between the legalization of adult-use cannabis and the incidence of fatal …

Read more

In the ongoing discourse surrounding the legalization of marijuana, a persistent concern has been its potential to normalize cannabis-impaired driving behaviors. Critics have expressed apprehension that the decriminalization of marijuana may inadvertently foster attitudes that condone driving under the influence of cannabis. However, a recent investigation conducted by researchers at Nationwide Children’s Hospital in conjunction with Ohio State University challenges …

Read more

The burgeoning medical cannabis industry has emerged as a significant economic force in the United States, with projected revenues nearing $32 billion annually. As dispensaries proliferate, the competitive landscape necessitates effective customer retention strategies to ensure sustained patronage. While many factors contribute to the success of a dispensary, one pivotal element that often remains underappreciated is the role of budtenders. …

Read more

The landscape of medicinal therapies in the United States is undergoing a transformative shift, highlighted by the recent legalization of medical cannabis in Kentucky, effective January 1, 2025. This pivotal legislation marks a significant milestone for healthcare practitioners and patients alike, particularly for those suffering from chronic conditions that can benefit from cannabinoid therapy. As Kentucky joins the ranks of …

Read more

Cannabigerol (CBG), a lesser-known cannabinoid derived from the Cannabis sativa plant, has garnered significant attention in recent scientific literature for its potential therapeutic applications. A recent review published in the journal *Molecules* outlines CBG’s capacity to modulate multiple physiological processes, suggesting that it may possess therapeutic power to alleviate a variety of conditions, notably cancer, metabolic disorders, pain, and inflammatory …

Read more

The dichotomy of cannabis strains is primarily centered around two main categories: Indica and Sativa. Each of these categories showcases distinct morphological and physiological characteristics, which contribute to their respective effects on the consumer. Historically, Indicas have been associated with sedation and relaxation, while Sativas are linked to a more invigorating, cerebral high. However, as research progresses, the categorization of …

Read more

The contemporary landscape of pharmacotherapy is evolving, with a growing emphasis on the integration of cannabis into clinical practice. A recent investigation published in the journal Health Economics explores the ramifications of incorporating medical marijuana into state Prescription Drug Monitoring Programs (PDMPs). The study reveals a duality of outcomes: while the addition of medical marijuana to PDMPs is associated with …

Read more

The recent approval by the U.S. Food and Drug Administration (FDA) for Phase 2 of a clinical trial investigating the efficacy of smoked medical marijuana in treating post-traumatic stress disorder (PTSD) in military veterans marks a significant milestone in psychiatric research. Funded by Michigan’s tax revenue from legal cannabis sales, and organized by the Multidisciplinary Association for Psychedelic Studies (MAPS), …

Read more